Editorial: improvement of cardiovascular risk factor control in patients with type 2 diabetes and nonalcoholic fatty liver disease—time for action! Authors' reply

LINKED CONTENT This article is linked to Zhang et al papers. To view these articles, visit https://doi.org/10.1111/apt.17428 and https://doi.org/10.1111/apt.17467

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Alimentary pharmacology & therapeutics 2023-05, Vol.57 (10), p.1172-1173
Hauptverfasser: Zhang, Xinrong, Wong, Grace Lai‐Hung, Wong, Vincent Wai‐Sun, Yip, Terry Cheuk‐Fung
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1173
container_issue 10
container_start_page 1172
container_title Alimentary pharmacology & therapeutics
container_volume 57
creator Zhang, Xinrong
Wong, Grace Lai‐Hung
Wong, Vincent Wai‐Sun
Yip, Terry Cheuk‐Fung
description LINKED CONTENT This article is linked to Zhang et al papers. To view these articles, visit https://doi.org/10.1111/apt.17428 and https://doi.org/10.1111/apt.17467
doi_str_mv 10.1111/apt.17474
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2806074973</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2805226380</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3484-aa5a6c3b0ed101e76dd00c9643ced58911537774515b9635a7730d37a0a7c36c3</originalsourceid><addsrcrecordid>eNp10UFu1DAUgGELgei0sOACyIhFYZHWjhM7YTeqClSqBIuyjt7YLxoXJw62M1V2HIIjcDJOUtMpLCrVG2--90v2I-QVZyc8n1OY0glXlaqekBUXsi5KJuRTsmKlbIuy4eKAHMZ4zRiTipXPyYFQrK1EKVbk97mxyQcL7gO1wxT8DgccE_U91RCM9TuIenYQaLDxO-1BZ021H1PwjtqRTpBsHoj0xqYtTcuEtKTGwgYTRgqjoaMfwWm_9c7qHEhpoc7uMGQVESL--fkr2QFpn8M5b_34hq7ntPUhHtOAk1tekGc9uIgv7-8j8u3j-dXZ5-Lyy6eLs_VloUXVVAVADVKLDUPDGUcljWFMt7ISGk3dtJzXQilV1bzetFLUoJRgRihgoLTIk0fk3b6b_-HHjDF1g40anYMR_Ry7smGSqapVItO3D-i1n0N-6J2qy1KKhmX1fq908DEG7Lsp2AHC0nHW_V1dl1fX3a0u29f3xXkzoPkv_-0qg9M9uLEOl8dL3frr1T55C3k4pbg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2805226380</pqid></control><display><type>article</type><title>Editorial: improvement of cardiovascular risk factor control in patients with type 2 diabetes and nonalcoholic fatty liver disease—time for action! Authors' reply</title><source>MEDLINE</source><source>Wiley Free Content</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Wiley Online Library All Journals</source><creator>Zhang, Xinrong ; Wong, Grace Lai‐Hung ; Wong, Vincent Wai‐Sun ; Yip, Terry Cheuk‐Fung</creator><creatorcontrib>Zhang, Xinrong ; Wong, Grace Lai‐Hung ; Wong, Vincent Wai‐Sun ; Yip, Terry Cheuk‐Fung</creatorcontrib><description>LINKED CONTENT This article is linked to Zhang et al papers. To view these articles, visit https://doi.org/10.1111/apt.17428 and https://doi.org/10.1111/apt.17467</description><identifier>ISSN: 0269-2813</identifier><identifier>EISSN: 1365-2036</identifier><identifier>DOI: 10.1111/apt.17474</identifier><identifier>PMID: 37094323</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Cardiovascular Diseases ; Cardiovascular system ; Diabetes mellitus (non-insulin dependent) ; Diabetes Mellitus, Type 2 ; Fatty liver ; Heart Disease Risk Factors ; Humans ; Liver diseases ; Non-alcoholic Fatty Liver Disease ; Risk Factors</subject><ispartof>Alimentary pharmacology &amp; therapeutics, 2023-05, Vol.57 (10), p.1172-1173</ispartof><rights>2023 John Wiley &amp; Sons Ltd.</rights><rights>Copyright © 2023 John Wiley &amp; Sons Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3484-aa5a6c3b0ed101e76dd00c9643ced58911537774515b9635a7730d37a0a7c36c3</cites><orcidid>0000-0002-2863-9389 ; 0000-0002-1819-2464 ; 0000-0003-2215-9410</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fapt.17474$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fapt.17474$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1416,1432,27923,27924,45573,45574,46408,46832</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37094323$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zhang, Xinrong</creatorcontrib><creatorcontrib>Wong, Grace Lai‐Hung</creatorcontrib><creatorcontrib>Wong, Vincent Wai‐Sun</creatorcontrib><creatorcontrib>Yip, Terry Cheuk‐Fung</creatorcontrib><title>Editorial: improvement of cardiovascular risk factor control in patients with type 2 diabetes and nonalcoholic fatty liver disease—time for action! Authors' reply</title><title>Alimentary pharmacology &amp; therapeutics</title><addtitle>Aliment Pharmacol Ther</addtitle><description>LINKED CONTENT This article is linked to Zhang et al papers. To view these articles, visit https://doi.org/10.1111/apt.17428 and https://doi.org/10.1111/apt.17467</description><subject>Cardiovascular Diseases</subject><subject>Cardiovascular system</subject><subject>Diabetes mellitus (non-insulin dependent)</subject><subject>Diabetes Mellitus, Type 2</subject><subject>Fatty liver</subject><subject>Heart Disease Risk Factors</subject><subject>Humans</subject><subject>Liver diseases</subject><subject>Non-alcoholic Fatty Liver Disease</subject><subject>Risk Factors</subject><issn>0269-2813</issn><issn>1365-2036</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp10UFu1DAUgGELgei0sOACyIhFYZHWjhM7YTeqClSqBIuyjt7YLxoXJw62M1V2HIIjcDJOUtMpLCrVG2--90v2I-QVZyc8n1OY0glXlaqekBUXsi5KJuRTsmKlbIuy4eKAHMZ4zRiTipXPyYFQrK1EKVbk97mxyQcL7gO1wxT8DgccE_U91RCM9TuIenYQaLDxO-1BZ021H1PwjtqRTpBsHoj0xqYtTcuEtKTGwgYTRgqjoaMfwWm_9c7qHEhpoc7uMGQVESL--fkr2QFpn8M5b_34hq7ntPUhHtOAk1tekGc9uIgv7-8j8u3j-dXZ5-Lyy6eLs_VloUXVVAVADVKLDUPDGUcljWFMt7ISGk3dtJzXQilV1bzetFLUoJRgRihgoLTIk0fk3b6b_-HHjDF1g40anYMR_Ry7smGSqapVItO3D-i1n0N-6J2qy1KKhmX1fq908DEG7Lsp2AHC0nHW_V1dl1fX3a0u29f3xXkzoPkv_-0qg9M9uLEOl8dL3frr1T55C3k4pbg</recordid><startdate>202305</startdate><enddate>202305</enddate><creator>Zhang, Xinrong</creator><creator>Wong, Grace Lai‐Hung</creator><creator>Wong, Vincent Wai‐Sun</creator><creator>Yip, Terry Cheuk‐Fung</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>7U9</scope><scope>H94</scope><scope>M7N</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-2863-9389</orcidid><orcidid>https://orcid.org/0000-0002-1819-2464</orcidid><orcidid>https://orcid.org/0000-0003-2215-9410</orcidid></search><sort><creationdate>202305</creationdate><title>Editorial: improvement of cardiovascular risk factor control in patients with type 2 diabetes and nonalcoholic fatty liver disease—time for action! Authors' reply</title><author>Zhang, Xinrong ; Wong, Grace Lai‐Hung ; Wong, Vincent Wai‐Sun ; Yip, Terry Cheuk‐Fung</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3484-aa5a6c3b0ed101e76dd00c9643ced58911537774515b9635a7730d37a0a7c36c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Cardiovascular Diseases</topic><topic>Cardiovascular system</topic><topic>Diabetes mellitus (non-insulin dependent)</topic><topic>Diabetes Mellitus, Type 2</topic><topic>Fatty liver</topic><topic>Heart Disease Risk Factors</topic><topic>Humans</topic><topic>Liver diseases</topic><topic>Non-alcoholic Fatty Liver Disease</topic><topic>Risk Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhang, Xinrong</creatorcontrib><creatorcontrib>Wong, Grace Lai‐Hung</creatorcontrib><creatorcontrib>Wong, Vincent Wai‐Sun</creatorcontrib><creatorcontrib>Yip, Terry Cheuk‐Fung</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>MEDLINE - Academic</collection><jtitle>Alimentary pharmacology &amp; therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhang, Xinrong</au><au>Wong, Grace Lai‐Hung</au><au>Wong, Vincent Wai‐Sun</au><au>Yip, Terry Cheuk‐Fung</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Editorial: improvement of cardiovascular risk factor control in patients with type 2 diabetes and nonalcoholic fatty liver disease—time for action! Authors' reply</atitle><jtitle>Alimentary pharmacology &amp; therapeutics</jtitle><addtitle>Aliment Pharmacol Ther</addtitle><date>2023-05</date><risdate>2023</risdate><volume>57</volume><issue>10</issue><spage>1172</spage><epage>1173</epage><pages>1172-1173</pages><issn>0269-2813</issn><eissn>1365-2036</eissn><abstract>LINKED CONTENT This article is linked to Zhang et al papers. To view these articles, visit https://doi.org/10.1111/apt.17428 and https://doi.org/10.1111/apt.17467</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>37094323</pmid><doi>10.1111/apt.17474</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0002-2863-9389</orcidid><orcidid>https://orcid.org/0000-0002-1819-2464</orcidid><orcidid>https://orcid.org/0000-0003-2215-9410</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0269-2813
ispartof Alimentary pharmacology & therapeutics, 2023-05, Vol.57 (10), p.1172-1173
issn 0269-2813
1365-2036
language eng
recordid cdi_proquest_miscellaneous_2806074973
source MEDLINE; Wiley Free Content; EZB-FREE-00999 freely available EZB journals; Wiley Online Library All Journals
subjects Cardiovascular Diseases
Cardiovascular system
Diabetes mellitus (non-insulin dependent)
Diabetes Mellitus, Type 2
Fatty liver
Heart Disease Risk Factors
Humans
Liver diseases
Non-alcoholic Fatty Liver Disease
Risk Factors
title Editorial: improvement of cardiovascular risk factor control in patients with type 2 diabetes and nonalcoholic fatty liver disease—time for action! Authors' reply
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T14%3A30%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Editorial:%20improvement%20of%20cardiovascular%20risk%20factor%20control%20in%20patients%20with%20type%202%20diabetes%20and%20nonalcoholic%20fatty%20liver%20disease%E2%80%94time%20for%20action!%20Authors'%20reply&rft.jtitle=Alimentary%20pharmacology%20&%20therapeutics&rft.au=Zhang,%20Xinrong&rft.date=2023-05&rft.volume=57&rft.issue=10&rft.spage=1172&rft.epage=1173&rft.pages=1172-1173&rft.issn=0269-2813&rft.eissn=1365-2036&rft_id=info:doi/10.1111/apt.17474&rft_dat=%3Cproquest_cross%3E2805226380%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2805226380&rft_id=info:pmid/37094323&rfr_iscdi=true